Answers are grounded in this paper and cite their sources.
We have recently shown that fluorescence spectroscopy of plasma samples has promising abilities regarding early detection of colorectal cancer. In the present paper, these results were further developed by combining fluorescence with the biomarkers, CEA and TIMP-1 and traditional metabolomic measurements in the form of (1)H NMR spectroscopy. The results indicate that using an extensive profile established by combining such measurements together with the biomarkers is better than using single markers.
No takes yet. Share an insight, caveat, or question.
Bro et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: